| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.083 | 0.009 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |